Product Information
METOPROLOL SUCC ER 200 MG TAB is a generic product labeled by AvPAK, priced at $0.1880 per EA under NDC 50268054315. Its NADAC has been published 405 times since Jan 2, 2019.
FDA first approved this application on Aug 15, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
AvPAKNDC
50268054315
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOPROLOL SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA078889FDA Approved
8/15/2012
TE Code
AB
On Market Since
7/25/2018
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL SUCC ER 200 MG TAB has been published 405 times since Jan 2, 2019, and over the history we have for it it has declined 63.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1880 per EA |
|---|---|
| All-time high | $0.5573 (Aug 14, 2019) |
| All-time low | $0.1284 (Nov 20, 2024) |
| 52-week high | $0.1997 |
| 52-week low | $0.1588 |
| Median price | $0.2235 |
| Average price | $0.2878 |
| Largest weekly change | +48.9% (Aug 23, 2023) |
| Weeks tracked | 405 |
| Tracking since | Jan 2, 2019 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AvPAK manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metoprolol succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOPROLOL SUCC ER 200 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 200 MG TAB, manufactured by AvPAK, is $0.1880 per EA (NDC 50268054315), effective Sep 30, 2026.
How has the price of METOPROLOL SUCC ER 200 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL SUCC ER 200 MG TAB has declined 63.2%. It has been tracked across 405 weekly CMS publications since Jan 2, 2019.
What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 200 MG TAB?
Since Jan 2, 2019, the NADAC for METOPROLOL SUCC ER 200 MG TAB has ranged from a low of $0.1284 (Nov 20, 2024) to a high of $0.5573 (Aug 14, 2019), with a median of $0.2235 per EA.
Are there cheaper alternatives to METOPROLOL SUCC ER 200 MG TAB?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METOPROLOL SUCC ER 200 MG TAB, is $0.1734 per EA — about 8% below METOPROLOL SUCC ER 200 MG TAB.
Who manufactures METOPROLOL SUCC ER 200 MG TAB?
METOPROLOL SUCC ER 200 MG TAB (NDC 50268054315) is labeled by AvPAK, and CMS classifies it as a generic product.